# Olema Pharmaceuticals, Inc.: Form 8-K, filed Aug 6, 2024

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2024-08-06
- Accepted by EDGAR: Aug 6, 2024, 20:10 ET
- Period: 2024-08-06
- Accession: 0000950170-24-091799
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000095017024091799/olma-20240806.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000095017024091799/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000095017024091799/olma-20240806.htm

Filed Aug 6, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-091799. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.